Trial Profile
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib - a Randomized, Controlled Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2023
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary) ; Dacarbazine; Docetaxel; Doxorubicin; Gemcitabine; Ifosfamide; Paclitaxel; Trabectedin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms PazoQol
- 15 Sep 2021 Status changed from recruiting to discontinued.
- 18 Jul 2020 This trial has been discontinued in Germany, according to European Clinical Trials Database record.
- 08 Mar 2018 New trial record